病例报告显示,由于阿米奥达龙诱导的脂症导致的进展性功能障碍
Mirjam D Duineveld1, Jesper Kers2, Louis-Jean Vleming3
1Division of Cardiology, Department of Medicine, Haga Teaching Hospital, Els Borst-Eilersplein 275, The Hague 2545 AA, The Netherlands.
European heart journal. Case reports
|September 25, 2023
概括
阿米奥达龙可以通过脂积累引起脏损伤. 这一案例表明,停止阿米奥达龙可以部分逆转这种脏毒性,这表明需要对脏进行监测.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 阿米奥达龙因肺部,甲状腺和肝脏的毒性而闻名.
- 由阿米奥达龙诱导的脂症引起的脏毒性是未被认可的.
- 这项研究侧重于一种特定的阿米奥达龙诱导的毒性病例.
研究的目的:
- 报告一种急性至慢性脏疾病的病例,这是阿米奥达龙的次要病例.
- 为了突出阿米奥达龙诱导的脏脂症的潜力.
- 建议在amiodarone监测指南中包括功能监测.
主要方法:
- 一个86岁的男性患者的病例报告.
- 脏活检以确定细胞内脂积累.
- 在停止使用阿米奥达龙之前和之后,对血清肌素水平的监测.
主要成果:
- 患者在阿米奥达龙启动后出现了急性至慢性病.
- 脏活检证实了脂化症.
- 停用阿米奥达龙后血清肌素的改善.
结论:
- 阿米奥达龙诱导的溶酶体脂症可能导致部分可逆性脏疾病.
- 目前的指导方针缺乏在阿米奥达龙治疗期间对脏毒性查的建议.
- 在接受阿米奥达龙的患者中,应考虑查脏毒性.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...


